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The Dangers of Gardening
Nocardia Infection in an immunocompromised gardener






Susceptibility Patterns of Nocardia
CT Chest From Admission
Nocardia is a gram-positive, partially-acid fast, 
branching bacillus that is ubiquitous in the 
landscape.  It is most often an opportunistic 
pathogen that can have devastating effects.  
As such, a high clinical suspicion is warranted, 
as is a thorough approach to the evaluation of 
the immunocompromised patient.
Important Features of Nocardia Infections
• Environmental Concerns: Nocardia 
species are found throughout the world in 
soil and decaying plant matter.  It is 
important to educate immunosuppressed 
patients on the importance of avoiding 
careers or hobbies such as gardening in 
which they are closely involved with such 
environs.
• Neurologic Involvement: Nocardia has a 
predilection for subcutaneous, pulmonary, 
and neurologic tissues.  Close neurologic 
monitoring and imaging may be necessary.
• Risk Factors: The most definitive risk factor 
is being immunocompromised.  High-dose 
steroids, history of CMV, and high levels of 
Calcineurin inhibitors may be independent 
risk factors.
Treatment & Prophylaxis
• Heterogeneity of Susceptibility: What was 
once suspected to be one species is now 
many, with demonstration of variable 
susceptibility.
• Duration: Treatment is prolonged, 
especially with disseminated or neurologic 
disease, typically including 3-6 weeks of 
multiple IV antibiotics, followed by 1 year of 
oral monotherapy in the 
immunocompromised.
• Prophylaxis: Currently, no guidelines for 
primary prophylaxis exist, but in 
immunocompromised individuals, secondary 
prophylaxis is recommended.
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History
A 56-year-old Filipino-American male with 
chronic kidney disease and a history of renal 
transplant in 2008 on chronic 
immunosuppression, presenting with a 1.5-week 
history of fever and cough.  
• In the past 3 months, he has been treated for 
pneumonia twice.
• Travelled to the Philippines 2 weeks ago.
• Also complained of posterior axillar pain.
Baseline Exam
• Vitals:  37.8, 103/66, 117, 18, 96% on room 
air
• Lungs:  Clear to auscultation.
• Integumentary:  Posterior axillary mass, non-
erythematous, mildly tender to palpation
Pertinent Findings
• Labs:  WBC 9.3, ALT 448, AST 80, Creatinine 
2.02 (baseline 1.70), Tacrolimus level 9.3
• Imaging:  
• CT chest: diffuse airspace opacities, worst 
at right upper lobe.
• MRI brain:  Within normal limits.
• CT abdomen/pelvis:  Within normal limits.
• Micro:
• Sputum AFB negative x3.
• CMV NAAT 410,000.
• Blood, sputum, and axillary & calf 
abscess cultures:  Nocardia nova.
Clinical Course
• Admitted and started on Ceftriaxone and 
Azithromycin for community acquired 
pneumonia.
• Cultures demonstrated positivity for 
branching gram positive bacilli, started on 
Imipenem and Trimethoprim-
Sulfamethoxazole.
• Worsening kidney injury and hyponatremia, 
sensitivities of Nocardia returned and 
transitioned to Ceftriaxone.
• Discharged in stable condition.
Nocardia infections present with a variety of 
findings, which can range from indolent to 
acute.  Immunocompromised patients, 
especially those with pertinent exposure 
histories, warrant close monitoring and 
workup. Treatment with multiple antibiotics 
including TMP-SMX in combination with 
Imipenem or Amikacin is used until 
sensitivities are available.
Gram Stain
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Antibiotic N. asteroides
complex
N. farcinica N. nova N. brasiliensis
TMP-SMX 91-100 89-100 89-100 100
Imipenem 70-100 65-100 100 0-25
Amikacin 85-100 100 100 100
Minocycline 95-100 12 35-100 75-90
Ceftriaxone 75-100 5-22 70-100 50-100
Ciprofloxacin 25-50 55-90 0 0-30
Amoxicillin-
Clavulanate
40-70 40-100 5-50 65-100
Linezolid 100 100 100 100
Moxifloxacin 50 88 X X
